On Tuesday, Rhythm Pharmaceuticals Inc (NASDAQ: RYTM) opened higher 3.39% from the last session, before settling in for the closing price of $59.92. Price fluctuations for RYTM have ranged from $31.52 to $68.58 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 175.40% annually for the last half of the decade. Company’s average yearly earnings per share was noted -36.17% at the time writing. With a float of $54.81 million, this company’s outstanding shares have now reached $59.43 million.
In an organization with 226 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 88.28%, operating margin of -235.95%, and the pretax margin is -229.52%.
Rhythm Pharmaceuticals Inc (RYTM) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Rhythm Pharmaceuticals Inc is 10.82%, while institutional ownership is 101.11%. The most recent insider transaction that took place on Nov 11 ’24, was worth 4,434,882. In this transaction EVP, Head of North America of this company sold 66,861 shares at a rate of $66.33, taking the stock ownership to the 972 shares. Before that another transaction happened on Nov 11 ’24, when Company’s Chief Technical Officer sold 13,281 for $66.44, making the entire transaction worth $882,341. This insider now owns 0 shares in total.
Rhythm Pharmaceuticals Inc (RYTM) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.7 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.71) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.78 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -36.17% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -9.00% during the next five years compared to -6.04% drop over the previous five years of trading.
Rhythm Pharmaceuticals Inc (NASDAQ: RYTM) Trading Performance Indicators
Check out the current performance indicators for Rhythm Pharmaceuticals Inc (RYTM). In the past quarter, the stock posted a quick ratio of 3.34. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 33.83.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.34, a number that is poised to hit -0.75 in the next quarter and is forecasted to reach -2.67 in one year’s time.
Technical Analysis of Rhythm Pharmaceuticals Inc (RYTM)
Let’s dig in a bit further. During the last 5-days, its volume was 0.51 million. That was inferior than the volume of 0.55 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 58.00%. Additionally, its Average True Range was 2.87.
During the past 100 days, Rhythm Pharmaceuticals Inc’s (RYTM) raw stochastic average was set at 76.30%, which indicates a significant increase from 49.81% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 53.51% in the past 14 days, which was higher than the 50.85% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $53.73, while its 200-day Moving Average is $45.91. However, in the short run, Rhythm Pharmaceuticals Inc’s stock first resistance to watch stands at $63.27. Second resistance stands at $64.58. The third major resistance level sits at $66.42. If the price goes on to break the first support level at $60.12, it is likely to go to the next support level at $58.28. Assuming the price breaks the second support level, the third support level stands at $56.97.
Rhythm Pharmaceuticals Inc (NASDAQ: RYTM) Key Stats
There are currently 61,457K shares outstanding in the company with a market cap of 3.81 billion. Presently, the company’s annual sales total 77,430 K according to its annual income of -184,680 K. Last quarter, the company’s sales amounted to 33,250 K and its income totaled -43,640 K.
